Jacqueline S Garcia

51PUBLICATIONS
314CO-AUTHORS
Gene and molecular therapyHaematological tumoursMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Jul 29, 2026
Venetoclax and hypomethylating agents versus other therapies: an international, multicenter, retrospective cohort chart review study.

|Jul 07, 2026
Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm.

|Jun 30, 2026
A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML.

|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.

|Apr 09, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.

Jooho Chung, Mounica Vallurupalli, Sarah Noel

|Feb 24, 2026
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.

H Moses Murdock, Haesook T Kim, Katie Maurer

Pageof 9

Frequent Collaborators

19 joint publications

Marlise R Luskin

14 joint publications

Daniel J DeAngelo

11 joint publications

Eric S Winer

9 joint publications

Shai Shimony